Last reviewed · How we verify

NCT07487753: IASTM

Instrumental Soft Tissue Mobilization and Foam Rolling

Completed NA Last updated 23 March 2026
What this trial tests

NA trial testing Instrument-Assisted Soft Tissue Mobilization (IASTM) in Plantar Fasciitis, Chronic in 56 participants. Completed in 30 June 2025.

Timeline
15 April 2025
Primary endpoint
15 June 2025
30 June 2025

Quick facts

Lead sponsorManav Rachna International Institute of Research and Studies
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment56
Start date15 April 2025
Primary completion15 June 2025
Estimated completion30 June 2025
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Manav Rachna International Institute of Research and Studies

Who can join

Adults 18 to 45, any sex, with Plantar Fasciitis, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares instrument-assisted soft tissue mobilization (IASTM) and foam roller therapy in individuals with plantar fasciitis. Both groups receive structured exercises. The study evaluates changes in pain, ankle dorsiflexion range of motion, and functional ability after treatment to determine which intervention is more effective for improving symptoms and physical function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Instrument-Assisted Soft Tissue Mobilization (IASTM)

Trials testing the same drug.

Other recruiting trials for Plantar Fasciitis, Chronic

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07487753.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing